1-[3'-(N,N-dimethylamino)phenyl]-2-propanone | 73177-36-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-[3'-(N,N-dimethylamino)phenyl]-2-propanone
• 英文别名: 1-[3-(Dimethylamino)phenyl]-2-propanone；1-[3-(dimethylamino)phenyl]propan-2-one
• CAS: 73177-36-3
• 化学式: C₁₁H₁₅NO
• 分子量: 177.246
• InChiKey: LLZZDFTVWLHQFS-UHFFFAOYSA-N

物化性质

• 沸点：
  285.7±23.0 °C(Predicted)
• 密度：
  1.019±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[3'-(N,N-dimethylamino)phenyl]-2-propanone 在 ammonium acetate 、 sodium cyanoborohydride 作用下， 以 甲醇 为溶剂， 以39%的产率得到3-(2-aminopropyl)-N,N-dimethylaniline
  参考文献：
  名称：

  Transaminase-Mediated Amine Borrowing via Shuttle Biocatalysis

  摘要：

  DOI：

  10.1021/acs.orglett.1c03320
• 作为产物：
  描述：

  甲基溴化镁 、 2-(3-(dimethylamino)phenyl)-N-methoxy-N-methylacetamide 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 16.0h， 以84%的产率得到1-[3'-(N,N-dimethylamino)phenyl]-2-propanone
  参考文献：
  名称：

  Transaminase-Mediated Amine Borrowing via Shuttle Biocatalysis

  摘要：

  DOI：

  10.1021/acs.orglett.1c03320

文献信息

• [EN] COMPOUNDS AND THEIR METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：AGIOS PHARMACEUTICALS INC

  公开号：WO2014079150A1

  公开（公告）日：2014-05-30

  Provided are compounds of formula (I), which can inhibit glutaminase. Pharmaceutical compositions comprising these compounds and uses as glutaminase inhibitors for treating cancers thereof are also provided.

  提供了化合物的化学式(I)，可以抑制谷氨酸酶。还提供了包含这些化合物的药物组合物，并用作抑制谷氨酸酶以治疗相关癌症的用途。
• [EN] QUINOLINE DERIVATIVES AND USE THEREOF AS MYCOBACTERIAL INHIBITORS<br/>[FR] DERIVES DE QUINOLINE ET UTILISATION DE CEUX-CI EN TANT QU'INHIBITEURS MYCOBACTERIENS
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2005070430A1

  公开（公告）日：2005-08-04

  The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or the general Formula (Ib) the pharmaceutically acceptable acid or base addition salts thereof, the quaternary amines thereof, the stereochemically isomeric forms thereof, the tautomeric forms thereof and the N-oxide forms thereof. The claimed compounds are useful for the treatment of mycobacterial diseases.

  本发明涉及根据一般式(Ia)或一般式(Ib)的新型取代喹啉衍生物，其药学上可接受的酸或碱盐，其季铵盐，其立体化异构体形式，其互变异构体形式和其N-氧化物形式。所述化合物可用于治疗分枝杆菌病。
• Zheda-Phos for General α-Monoarylation of Acetone with Aryl Chlorides
  作者：Pengbin Li、Bo Lü、Chunling Fu、Shengming Ma

  DOI：10.1002/adsc.201300207

  日期：2013.5.3

  A new, readily available, and air‐stable monophosphine ligand, i.e., Zheda‐Phos, has been developed for the general and highly effective palladium‐catalyzed monoarylation of acetone with aryl chlorides. The reaction rate is of first‐order dependence with the aryl chloride.

  已经开发出一种新的，易于获得的，对空气稳定的单膦配体Zheda-Phos，用于丙酮与芳基氯化物的丙酮催化的一般的，高效的单芳基化反应。与芳基氯的反应速率是一阶依赖性的。
• DIALKYL(2-ALKOXY-6-AMINOPHENYL)PHOSPHINE, THE PREPARATION METHOD AND USE THEREOF
  申请人：Ma Shengming

  公开号：US20140309422A1

  公开（公告）日：2014-10-16

  The present invention relates to the compound of dialkyl(2-alkoxy-6-aminophenyl)phosphine and the preparation method thereof and the application in the palladium catalyzed coupling reactions of aryl chloride and ketone. The dialkyl(2-alkoxy-6-aminophenyl)phosphine of the present invention could coordinate with the palladium catalyst to highly selectively activate the inert carbon-chlorine bond, and to catalyze direct arylation reaction in the α-position of ketones to produce corresponding coupling compounds. The preparation method of the present invention is a simple one-step method which produces the air-stable dialkyl(2-alkoxy-6-aminophenyl)phosphine. Compared with the synthetic routes of ligands to be used in the activation of carbon-chlorine bonds in the prior arts, the preparation method of the present invention has the advantages of short route and easy operation.

  本发明涉及二烷基（2-烷氧基-6-氨基苯基）膦化合物及其制备方法，以及在钯催化芳基氯化物和酮的偶联反应中的应用。本发明的二烷基（2-烷氧基-6-氨基苯基）膦化合物能够与钯催化剂配位，高度选择性地活化惰性碳-氯键，并催化酮的α位直接芳基化反应，生成相应的偶联化合物。本发明的制备方法是一种简单的一步法，可制备出稳定于空气中的二烷基（2-烷氧基-6-氨基苯基）膦化合物。与先前用于活化碳-氯键的配体的合成路线相比，本发明的制备方法具有路线短、操作简便的优点。
• [EN] QUINOLINE DERIVATIVES AND THEIR USE AS MYCOBACTERIAL INHIBITORS<br/>[FR] DERIVES DE QUINOLEINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS MYCOBACTERIENS
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2004011436A1

  公开（公告）日：2004-02-05

  The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or the general Formula (Ib), the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof, the tautomeric forms thereof and the N-oxide forms thereof. The claimed compounds are useful for the treatment of mycobacterial diseases, particularly those diseases caused by pathogenic mycobacteria such as Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum. In particular, compounds are claimed in which, independently from each other, R1 is bromo, p=1, R2 is alkyloxy, R3 is optionally substituted naphthyl or phenyl, q=1, R4 and R5 each independently are hydrogen, methyl or ethyl, R6 is hydrogen, r is equal to 0 or 1 and R7 is hydrogen. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of mycobacterial diseases and a process for preparing the claimed compounds.

  本发明涉及根据通式(Ia)或通式(Ib)的新型取代喹啉衍生物，其药学上可接受的酸盐或碱盐，其立体化学异构体形式，其互变异构体形式和其N-氧化物形式。所述化合物对治疗结核分枝杆菌病等由病原性分枝杆菌引起的疾病有用，特别是对治疗结核分枝杆菌、博维氏分枝杆菌、埃维分枝杆菌和海洋分枝杆菌等疾病有用。特别地，所述化合物中，独立于彼此，R1为溴，p=1，R2为烷氧基，R3为可选择取代的萘基或苯基，q=1，R4和R5各自独立为氢、甲基或乙基，R6为氢，r等于0或1，R7为氢。还声明了一种包含药学上可接受载体和作为活性成分的所述化合物的治疗有效量的组合物，所述化合物或组合物用于制备治疗结核分枝杆菌病的药物以及制备所述化合物的方法。